FDA approves Alzheimer's drug seen by experts as big advance, but no miracle
The Food and Drug Administration on Friday approved an Alzheimer's drug, lecanemab, to be sold under the brand name Leqembi, which has modestly slowed cognitive decline in some people in the early stages of the disease.
Source: upi.com